TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 35779553

Group type: EXPERIMENTAL
Intervention: Intravenous tenecteplase (0.25 mg/kg to a maximum of 25 mg)
Number of subjects: 1600

Group type: COMPARATOR
Intervention: Alteplase (0.9 mg/kg to a maximum of 90 mg; 0.09 mg/kg as a bolus and then a 60 min infusion of the remaining 0.81 mg/kg)
Number of subjects: 1600

Group type: EXPERIMENTAL
Intervention: Intravenous tenecteplase
Number of subjects: 1600

Group type: COMPARATOR
Intervention: Alteplase
Number of subjects: 1600
Study: 34152102

Group type: EXPERIMENTAL
Intervention: Deliberate practice debriefing
Number of subjects: 50

Group type: COMPARATOR
Intervention: Standardized debriefing
Number of subjects: 50
Study: 34871098

Group type: EXPERIMENTAL
Intervention: Delpazolid 800 mg QD
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Delpazolid 400 mg BID
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Delpazolid 800 mg BID
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Delpazolid 1200 mg QD
Number of subjects: 79

Group type: COMPARATOR
Intervention: HRZE (isoniazid, rifampin, pyrazinamide, ethambutol)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Linezolid 600 mg BID
Number of subjects: 79
Study: 33641656

Group type: EXPERIMENTAL
Intervention: Probiotic-Inulin Co-supplementation
Number of subjects: 96

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 96
Study: 34508734

Group type: EXPERIMENTAL
Intervention: Preventure program
Number of subjects: 1005

Group type: EXPERIMENTAL
Intervention: Preventure program (internalising personality traits)
Number of subjects: 1005

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1005
Study: 33320168

Group type: EXPERIMENTAL
Intervention: 1% atropine once a day for 1 week, then once a week for 23 weeks
Number of subjects: 207

Group type: COMPARATOR
Intervention: 0.01% atropine once a day for 6 months
Number of subjects: 207
Study: 36228639

Group type: EXPERIMENTAL
Intervention: Colchicine 0.6 mg twice daily for 3 days and then 0.6 mg once daily for 25 days
Number of subjects: 3881

Group type: COMPARATOR
Intervention: Usual care (Control for colchicine)
Number of subjects: 3881

Group type: EXPERIMENTAL
Intervention: Aspirin 100 mg once daily for 28 days
Number of subjects: 3881

Group type: COMPARATOR
Intervention: Usual care (Control for aspirin)
Number of subjects: 3881

Group type: EXPERIMENTAL
Intervention: Colchicine
Number of subjects: 3881

Group type: EXPERIMENTAL
Intervention: Aspirin
Number of subjects: 3881
Study: 34628831

Group type: EXPERIMENTAL
Intervention: 30 mg oral prednisone once a day for 14 days (Group A)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: 45 mg oral prednisone once a day for 14 days (Group B)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: 60 mg oral prednisone once a day for 14 days (Group C)
Number of subjects: 150

Group type: COMPARATOR
Intervention: All groups (A, B, C)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Asthma patients in all groups
Number of subjects: 150
Study: 35152882

Group type: EXPERIMENTAL
Intervention: Endoscopic retrograde appendicitis therapy (ERAT)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Laparoscopic appendectomy (LA)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Open appendectomy (OA)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Control group (not applicable)
Number of subjects: 99
Study: 33410380

Group type: EXPERIMENTAL
Intervention: PDSA‐CRIF (Percutaneous Distractor and Subtalar Arthroscopy Closed Reduction followed by Internal Fixation)
Number of subjects: 59
Study: 34550915

Group type: EXPERIMENTAL
Intervention: Narrative intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study: 33478517

Group type: EXPERIMENTAL
Intervention: Vojta specific tactile input (V-STI)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Non-specific tactile input (non-STI)
Number of subjects: 40
Study: 35181556

Group type: EXPERIMENTAL
Intervention: Goal-directed fluid therapy (GDFT)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard care (SC)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: GDFT and SC
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: GDFT
Number of subjects: 60
Study: 33676342

Group type: EXPERIMENTAL
Intervention: Psychological inflexibility
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Trauma-related guilt (guilt cognitions, guilt distress, overall guilt)
Number of subjects: 85
Study: 32014493

Group type: EXPERIMENTAL
Intervention: Weight loss (diet and/or exercise)
Number of subjects: 105
Study: 36209196

Group type: EXPERIMENTAL
Intervention: Humor intervention (self-painted humorous business card)
Number of subjects: 132

Group type: COMPARATOR
Intervention: Standard breast examination
Number of subjects: 132
Study: 34285165

Group type: EXPERIMENTAL
Intervention: 1.9 µg HA/AS03B
Number of subjects: 185

Group type: EXPERIMENTAL
Intervention: 0.9 µg HA/AS03C
Number of subjects: 185

Group type: EXPERIMENTAL
Intervention: 1.9 µg HA/AS03C
Number of subjects: 185

Group type: EXPERIMENTAL
Intervention: 3.75 µg HA/AS03C
Number of subjects: 185

Group type: EXPERIMENTAL
Intervention: 3.75 µg HA/AS03D
Number of subjects: 185
Study: 33927696

Group type: EXPERIMENTAL
Intervention: Stepwise reduction of 12.5 IU rec-FSH daily in the Study group (SG)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Control group (CG) with standard gonadotropin stimulation
Number of subjects: 108
Study: 32470022

Group type: EXPERIMENTAL
Intervention: High H2 water (containing 7 ppm of H2: 3.5 mg H2 in 500-mL water)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Placebo (molecular nitrogen (N2)‐containing water)
Number of subjects: 68
Study: 34060416

Group type: EXPERIMENTAL
Intervention: BCG vaccine paste, administered once weekly for eight consecutive weeks
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 80
Study: 33291159

Group type: EXPERIMENTAL
Intervention: Prophylactic clip closure after endoscopic mucosal resection (EMR)
Number of subjects: 458

Group type: EXPERIMENTAL
Intervention: Factors associated with complete closure
Number of subjects: 458
Study: 33037080

Group type: EXPERIMENTAL
Intervention: Baricitinib treatment
Number of subjects: 274
Study: 615916148

Group type: EXPERIMENTAL
Intervention: Daily oral supplement containing 10mg lutein, 2mg zeaxanthin and 10mg meso-zeaxanthin for a period of 6 months
Number of subjects: 88

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 88
Study: 35997261

Group type: EXPERIMENTAL
Intervention: First STEPS intervention (peer parent coaching, structured behavioral counseling, professional consultations)
Number of subjects: 157

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: First STEPS intervention and Usual care
Number of subjects: 157
Study: 34750767

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 80

Group type: COMPARATOR
Intervention: 0.9% sodium chloride (control)
Number of subjects: 80
Study: 32605106

Group type: EXPERIMENTAL
Intervention: Run Interval Training (RIT), n = 9
Number of subjects: 19

Group type: COMPARATOR
Intervention: Non-exercise control (CON), n = 10
Number of subjects: 19
Study: 35976361

Group type: EXPERIMENTAL
Intervention: Group Medical Visits (GMVs)
Number of subjects: 152

Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 152
Study: 33080376

Group type: EXPERIMENTAL
Intervention: Cervical disc arthroplasty (CDA)
Number of subjects: 463

Group type: COMPARATOR
Intervention: Anterior cervical discectomy and fusion (ACDF)
Number of subjects: 463

Group type: EXPERIMENTAL
Intervention: CDA
Number of subjects: 463

Group type: COMPARATOR
Intervention: ACDF
Number of subjects: 463
Study: 32706780

Group type: EXPERIMENTAL
Intervention: Anodal‐Transcranial Direct Current Stimulation (A‐tDCS)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Sham A‐tDCS
Number of subjects: 20
Study: 34775413

Group type: EXPERIMENTAL
Intervention: Laparoscopic surgery
Number of subjects: 475

Group type: COMPARATOR
Intervention: Open surgery
Number of subjects: 475
Study: 33991802

Group type: EXPERIMENTAL
Intervention: Wii
Number of subjects: 20

Group type: COMPARATOR
Intervention: C (Cycloergometer)
Number of subjects: 20

Group type: COMPARATOR
Intervention: T (Treadmill)
Number of subjects: 20
Study: 32629007

Group type: EXPERIMENTAL
Intervention: Low-dose aspirin (COMPASS trial)
Number of subjects: 9126

Group type: COMPARATOR
Intervention: Low-dose aspirin (IMRD-UK cohort)
Number of subjects: 9126
Study: 35020938

Group type: EXPERIMENTAL
Intervention: Active Women over 50 Online program
Number of subjects: 62

Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 62
Study: 33059915

Group type: EXPERIMENTAL
Intervention: Platinum-based chemotherapy
Number of subjects: 179

Group type: EXPERIMENTAL
Intervention: High-grade tumors
Number of subjects: 179

Group type: EXPERIMENTAL
Intervention: Overall survival (OS)
Number of subjects: 179

Group type: EXPERIMENTAL
Intervention: Median follow-up
Number of subjects: 179
Study: 36384218

Group type: EXPERIMENTAL
Intervention: Lower-intensity telecare collaborative pain management (TCM)
Number of subjects: 820

Group type: COMPARATOR
Intervention: Higher-intensity integrated pain team management (IPT)
Number of subjects: 820

Group type: EXPERIMENTAL
Intervention: Switching to buprenorphine
Number of subjects: 820

Group type: COMPARATOR
Intervention: No option to switch to buprenorphine
Number of subjects: 820
Study: 33810904

Group type: EXPERIMENTAL
Intervention: Salk-Sabin-Sabin group
Number of subjects: 360

Group type: COMPARATOR
Intervention: Salk-Salk-Salk group
Number of subjects: 360
Study: 35652929

Group type: EXPERIMENTAL
Intervention: Hippotherapy combined with Schroth exercises
Number of subjects: 45

Group type: COMPARATOR
Intervention: Schroth exercises alone
Number of subjects: 45
Study: 32152202

Group type: EXPERIMENTAL
Intervention: hu14.18‐IL2 immunotherapy (Group A)
Number of subjects: 23

Group type: COMPARATOR
Intervention: hu14.18‐IL2 immunotherapy (Group B)
Number of subjects: 23
Study: 34845502

Group type: EXPERIMENTAL
Intervention: 250 mg abiraterone with a low-fat meal (LOW)
Number of subjects: 72

Group type: COMPARATOR
Intervention: 1,000 mg abiraterone fasting (STD)
Number of subjects: 72
Study: 32105198

Group type: EXPERIMENTAL
Intervention: Virtual Microscopy (VM)
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Conventional Microscopy (CM)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Control group (no workshop)
Number of subjects: 71
Study: 35212104

Group type: EXPERIMENTAL
Intervention: Ipragliflozin
Number of subjects: 68

Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 68
Study: 35507948

Group type: EXPERIMENTAL
Intervention: Chandelier-Assisted Scleral Buckling (CSB)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Standard Scleral Buckling (SSB)
Number of subjects: 49
Study: 34714505

Group type: EXPERIMENTAL
Intervention: Universal prevention program
Number of subjects: 678
Study: 34895218

Group type: EXPERIMENTAL
Intervention: Fevipiprant 150 mg
Number of subjects: 2538

Group type: EXPERIMENTAL
Intervention: Fevipiprant 450 mg
Number of subjects: 2538

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2538
Study: 32706124

Group type: EXPERIMENTAL
Intervention: Exposure-based cognitive behavior therapy (CBT) for anxiety related to asthma, 10-week protocol
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Exposure-based cognitive behavior therapy (CBT) for anxiety related to asthma
Number of subjects: 6
Study: 34488318

Group type: EXPERIMENTAL
Intervention: Risperidone + VR
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 43

Group type: COMPARATOR
Intervention: Control
Number of subjects: 43
Study: 32448894

Group type: EXPERIMENTAL
Intervention: Stopping prophylaxis when CD4 count was above 200 cells/µL for more than 3 months
Number of subjects: 4813

Group type: COMPARATOR
Intervention: Stopping prophylaxis when the patient was virologically suppressed (two consecutive HIV RNA ≤ 400c/mL)
Number of subjects: 4813
Study: 35361632

Group type: EXPERIMENTAL
Intervention: 1 g of methylprednisolone intravenously for 3 consecutive days
Number of subjects: 304
Study: 34065751

Group type: EXPERIMENTAL
Intervention: Early-life parent-child activities
Number of subjects: 323

Group type: EXPERIMENTAL
Intervention: Child-alone screen use duration
Number of subjects: 323

Group type: EXPERIMENTAL
Intervention: Video game exposure
Number of subjects: 323

Group type: EXPERIMENTAL
Intervention: Non-screen recreational parent-child activities
Number of subjects: 323
Study: 33001206

Group type: EXPERIMENTAL
Intervention: Antibody titers in sequential samples from serum donors recovering from COVID-19
Number of subjects: 0
Study: 35588357

Group type: EXPERIMENTAL
Intervention: Usual care plus breathing exercises (UC 1 BrEX)
Number of subjects: 193

Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 193
Study: 33068350

Group type: EXPERIMENTAL
Intervention: Acupoint injection of houttuynia cordata (3 mL each time, once a day for 3 injections, then once every two days for 3 times)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Artificial tears and anti-inflammatory drugs
Number of subjects: 60
Study: 35779545

Group type: EXPERIMENTAL
Intervention: If I Were Jack (gender-transformative relationships and sexuality education)
Number of subjects: 8216

Group type: COMPARATOR
Intervention: Standard RSE (control)
Number of subjects: 8216
Study: 33530252

Group type: EXPERIMENTAL
Intervention: Baduanjin exercise training
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group (not receiving any special exercise training)
Number of subjects: 90
Study: 34118745

Group type: EXPERIMENTAL
Intervention: Older adults
Number of subjects: 34

Group type: COMPARATOR
Intervention: Young adults
Number of subjects: 34
Study: 32446263

Group type: EXPERIMENTAL
Intervention: Probiotic supplementation (lower dosage) in cesarean-born neonates (CDL)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Probiotic supplementation (higher dosage) in cesarean-born neonates (CDH)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Cesarean delivery neonates (CD)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Probiotic supplementation (both dosages)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Probiotic supplementation
Number of subjects: 26
Study: 32352828

Group type: EXPERIMENTAL
Intervention: Shared book reading at 6 months
Number of subjects: 293

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 293
Study: 35217772

Group type: EXPERIMENTAL
Intervention: Exenatide 2.0 mg once weekly plus dapagliflozin 10 mg once daily
Number of subjects: 56

Group type: COMPARATOR
Intervention: Control group (Group B)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Exenatide plus dapagliflozin
Number of subjects: 56
Study: 32091358

Group type: EXPERIMENTAL
Intervention: Accelerated vaccine schedule (0 and 21 days)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Longer interval vaccine schedule (0 and 60 days)
Number of subjects: 0
Study: 35869375

Group type: EXPERIMENTAL
Intervention: Nicotine vaping products (NVPs) for 12 weeks
Number of subjects: 29
Study: 34847965

Group type: EXPERIMENTAL
Intervention: Nebulized ketamine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Intravenous magnesium sulfate
Number of subjects: 0
Study: 33122529

Group type: EXPERIMENTAL
Intervention: LMWH combined with insulin
Number of subjects: 476

Group type: COMPARATOR
Intervention: Insulin alone
Number of subjects: 476
Study: 36039334

Group type: EXPERIMENTAL
Intervention: Nomogram for predicting radiation-associated aspiration pneumonia (RAP)
Number of subjects: 453
Study: 35854638

Group type: EXPERIMENTAL
Intervention: Palovarotene 10/5 mg
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Palovarotene 5/2.5 mg
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 33320369

Group type: EXPERIMENTAL
Intervention: Amniotic membrane extract
Number of subjects: 2

Group type: COMPARATOR
Intervention: Control (amniotic membrane extract vehicle)
Number of subjects: 2
Study: 33663274

Group type: EXPERIMENTAL
Intervention: Visual flow speed at 7.5 km.h-1
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Visual flow speed at 15 km.h-1
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Visual flow speed at 22.5 km.h-1
Number of subjects: 18
Study: 32675583

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Nontreatment group
Number of subjects: 150
Study: 34475143

Group type: EXPERIMENTAL
Intervention: Prepectoral implant-based breast reconstruction (IBBR)
Number of subjects: 372

Group type: COMPARATOR
Intervention: Subpectoral implant-based breast reconstruction (IBBR)
Number of subjects: 372
Study: 33045009

Group type: EXPERIMENTAL
Intervention: Engagement of stakeholders in the design, evaluation, and dissemination of learning resources.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Evaluation of stakeholder engagement effectiveness.
Number of subjects: 0
Study: 35603694

Group type: EXPERIMENTAL
Intervention: Augmented reality coupled pamphlet
Number of subjects: 60

Group type: COMPARATOR
Intervention: Simple pamphlet
Number of subjects: 60
Study: 33392650

Group type: EXPERIMENTAL
Intervention: Tethered cord syndrome (TCS) group
Number of subjects: 151

Group type: COMPARATOR
Intervention: Control group (300 randomly selected examinees)
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: TCS group
Number of subjects: 151
Study: 33415556

Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy and surgery
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Neoadjuvant treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Chemoradiation
Number of subjects: 0
Study: 33589674

Group type: EXPERIMENTAL
Intervention: Cocoa flavanols (260, 510, and 770 mg/day) for 12 weeks
Number of subjects: 211

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 211

Group type: EXPERIMENTAL
Intervention: MRI substudy
Number of subjects: 211
Study: 32868525

Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy
Number of subjects: 991

Group type: COMPARATOR
Intervention: Surgery alone (Control)
Number of subjects: 991

Group type: EXPERIMENTAL
Intervention: G3 tumors in the microsatellite stable/microsatellite instability-low subset
Number of subjects: 991
Study: 36069785

Group type: EXPERIMENTAL
Intervention: Internet-delivered cognitive behavioral therapy (ICBT) course (5-week duration)
Number of subjects: 308

Group type: COMPARATOR
Intervention: Motivational interviewing (MI) before treatment
Number of subjects: 308

Group type: COMPARATOR
Intervention: Self-guided booster lesson (1 month after treatment)
Number of subjects: 308
Study: 33140132

Group type: EXPERIMENTAL
Intervention: Transitional Care Model (TCM) components
Number of subjects: 39
Study: 32092190

Group type: EXPERIMENTAL
Intervention: High-intensity exercise rehabilitation (supervised 3 times a week for 16 weeks)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: High-intensity exercise rehabilitation
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Chronic exercise
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Acute exercise
Number of subjects: 55

Group type: COMPARATOR
Intervention: Sleep hygiene control (in-person discussion and monthly phone calls)
Number of subjects: 55
Study: 34719577

Group type: EXPERIMENTAL
Intervention: Propranolol gel 1%
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Propranolol gel 5%
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 32761810

Group type: EXPERIMENTAL
Intervention: Er:YAG laser irradiation
Number of subjects: 24

Group type: COMPARATOR
Intervention: Open flap mechanical debridement, supracrestal implantoplasty, bone grafting, and acellular dermal matrix membrane (Control group)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: No/minor membrane exposure
Number of subjects: 24
Study: 36451472

Group type: EXPERIMENTAL
Intervention: Surgery according to the ECASES system
Number of subjects: 202

Group type: COMPARATOR
Intervention: Surgery according to the operator's experience
Number of subjects: 202
Study: 34292643

Group type: EXPERIMENTAL
Intervention: ozanimod 0.46 mg or 0.92 mg daily
Number of subjects: 1346

Group type: COMPARATOR
Intervention: interferon β‐1a 30 µg weekly
Number of subjects: 1346

Group type: EXPERIMENTAL
Intervention: ozanimod
Number of subjects: 1346
Study: 33105368

Group type: EXPERIMENTAL
Intervention: Probiotic (Bacillus subtilis) supplementation (DE111; 5 billion CFU/day)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 23
Study: 33849654

Group type: EXPERIMENTAL
Intervention: Rheport
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: Ada
Number of subjects: 164
Study: 36326860

Group type: EXPERIMENTAL
Intervention: Interferential current stimulation (IF), applied 3 days a week for 8 weeks
Number of subjects: 25

Group type: COMPARATOR
Intervention: Sham IF, applied 3 days a week for 8 weeks
Number of subjects: 25
Study: 34360284

Group type: EXPERIMENTAL
Intervention: High-traffic (HT) area exposure to traffic-related air pollution (TRAP)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Low-traffic (LT) area exposure to traffic-related air pollution (TRAP)
Number of subjects: 0
Study: 32800307

Group type: EXPERIMENTAL
Intervention: Provider-Rated TranS-C Checklist
Number of subjects: 101

Group type: COMPARATOR
Intervention: Independent-Rater TranS-C Checklist
Number of subjects: 101
Study: 36064434

Group type: EXPERIMENTAL
Intervention: Lacosamide
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pregabalin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tapentadol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 32530041

Group type: EXPERIMENTAL
Intervention: Performance-Based Financing (PBF) intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Decentralized Facility Financing (DFF)
Number of subjects: 0
Study: 32890302

Group type: EXPERIMENTAL
Intervention: 5-Chair Stand test
Number of subjects: 248

Group type: EXPERIMENTAL
Intervention: Physical performance tests and PROMs
Number of subjects: 248

Group type: EXPERIMENTAL
Intervention: Physical performance tests
Number of subjects: 248
Study: 35508892

Group type: EXPERIMENTAL
Intervention: Sodium phenylbutyrate and taurursodiol (PB and TURSO)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 33834318

Group type: EXPERIMENTAL
Intervention: Immediate ART initiation (EAAA)
Number of subjects: 2261

Group type: COMPARATOR
Intervention: Standard of care (ART eligibility below a CD4 count threshold)
Number of subjects: 2261
Study: 35026498

Group type: EXPERIMENTAL
Intervention: GM‐CSF mouthwash
Number of subjects: 91

Group type: COMPARATOR
Intervention: Salt and Soda mouthwash
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Salt and Soda during prevention followed by GM‐CSF at onset of OM
Number of subjects: 91